Covance Inc (CVD) financial statements (2020 and earlier)

Company profile

Business Address 210 CARNEGIE CENTER
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments729493
Cash and cash equivalents618493
Short-term investments111 
Receivables332340
Inventory, net of allowances, customer advances and progress billings4849
Inventory4849
Prepaid expense and other current assets168
Income taxes receivable 4
Deferred tax assets5245
Other undisclosed current assets343137
Total current assets:1,5041,235
Noncurrent Assets
Property, plant and equipment914891
Intangible assets, net (including goodwill)118119
Goodwill110110
Intangible assets, net (excluding goodwill)89
Other noncurrent assets29
Prepaid expense and other noncurrent assets52
Assets held-for-sale, long lived7 
Deferred tax assets, net(32)(28)
Other undisclosed noncurrent assets1819
Total noncurrent assets:1,0531,054
TOTAL ASSETS:2,5572,288
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities238179
Accounts payable6034
Employee-related liabilities171145
Taxes payable8 
Debt 320
Other liabilities154128
Other undisclosed current liabilities240256
Total current liabilities:633883
Noncurrent Liabilities
Long-term debt and lease obligation250 
Long-term debt, excluding current maturities250 
Liabilities, other than long-term debt148143
Deferred tax liabilities, net7173
Other liabilities7771
Other undisclosed noncurrent liabilities(39)(45)
Total noncurrent liabilities:35999
Total liabilities:991981
Stockholders' equity
Stockholders' equity attributable to parent1,5651,307
Common stock11
Treasury stock, value(1,101)(1,067)
Additional paid in capital860744
Accumulated other comprehensive income2629
Retained earnings1,7801,601
Total stockholders' equity:1,5651,307
TOTAL LIABILITIES AND EQUITY:2,5572,288

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Revenues2,5952,366
Cost of revenue(2,371)(2,211)
Gross profit:224155
Operating expenses(7)(39)
Operating income:217116
Nonoperating income (expense)10(11)
Investment income, nonoperating32
Foreign currency transaction loss, before tax(2)(1)
Interest and debt expense(7)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes76
Income from continuing operations before equity method investments, income taxes:228105
Income from equity method investments 0
Income from continuing operations before income taxes:228105
Income tax expense(49)(10)
Net income available to common stockholders, diluted:17995

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net income:17995
Comprehensive income:17995
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)24
Comprehensive income, net of tax, attributable to parent:176119

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: